InvestorsObserver is giving Recro Pharma Inc (REPH) an Analyst Rating Rank of 78, meaning REPH is ranked higher by analysts than 78% of stocks. The average price target for REPH is $5 and analyst’s rate the stock as a Strong Buy
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Recro Pharma Inc Stock Today?
Recro Pharma Inc (REPH) stock is trading at $3.54 as of 11:14 AM on Friday, Feb 26, a loss of -$1.37, or -28% from the previous closing price of $4.91. The stock has traded between $3.41 and $3.98 so far today. Volume today is high. So far 1,730,065 shares have traded compared to average volume of 814,649 shares.
Click Here to get the full report on Recro Pharma Inc (REPH) Stock.
